Li Xin Chen

6445734, Sep 3, 2002

Jun 30, 1999

09/343873

Li Chen - Irvine CA
Farhad Aminian - Irvine CA
Keith T. Chu - Laguna Niguel CA

Conexant Systems, Inc. - Newport Beach CA

H03H 730

375231, 375232, 375350, 708305, 708323

Equalizer training is validated by techniques to detect false training. The validation techniques involve checking the unique time domain energy shaping of a plurality of taps of a trained equalizer of a modem for good training. The energy measure for each equalizer tap of the plurality of taps is approximated by summing the magnitude of a real component and a magnitude of an imaginary component of an equalizer coefficient corresponding to the equalizer tap. A tap with a highest approximate energy (i. e. , the main tap) is then determined. Next, the main tap energy is compared to a main tap threshold and a predetermined guarding threshold. The plurality of taps are arranged in a time index ordered sequence. In determining the main tap threshold, a first energy sum of a beginning set of taps in the sequence is compared with a second energy sum of a last set of taps in the sequence. The lesser tap energy sum between the first energy sum and the second energy sum is the main tap threshold.

7654672, Feb 2, 2010

Oct 31, 2008

12/263433

Huawei Zhao - Irvine CA, US
Li Chen - Santa Clara CA, US

Abbott Medical Optics Inc. - Santa Ana CA

A61B 3/10

351221, 351205

A system for providing vision contains an aberrometer, a wavefront sensor, and a transfer optical system. The aberrometer is configured to measure a received wavefront. The aberrometer includes a wavefront sensor and a transfer optical system for transferring an input wavefront so as to the provide the received wavefront at or near the wavefront sensor. The system also includes a processor in communication with the aberrometer, a readable memory, and instructions located within the memory. The readable memory contains one or more system error parameters and instructions available to the processor. The instructions are for determining at least one aberration of the received wavefront and calculating the input wavefront based on the received wavefront and the one or more system error parameters.

7875598, Jan 25, 2011

Mar 4, 2004

10/795554

Wenyuan Shi - Los Angeles CA, US
Li Chen - Los Angeles CA, US
Qing-yi Lu - Los Angeles CA, US
David Heber - Los Angeles CA, US
Maxwell H. Anderson - Seattle WA, US

The Regents of the University of California - Oakland CA

A61K 31/58
A61K 31/70
A01N 43/04
C07J 71/00

514172, 514 27, 540 17

The present invention is based on the discovery that certain chemical compounds isolated from Chinese medicinal herbs are useful as anti-microbial agents, e. g. , anti-bacterial agents, anti-fungal agents, and the like. In particular, the present invention provides compositions useful for treating microbial infections such as, for example, oral microbial infections, including periodontal disease and dental caries.

8162480, Apr 24, 2012

Dec 30, 2009

12/650130

Huawei Zhao - Irvine CA, US
Li Chen - Santa Clara CA, US

Abbott Medical Optics Inc. - Santa Ana CA

A61B 3/10

351221, 351205

A system for providing vision contains an aberrometer, a wavefront sensor, and a transfer optical system. The aberrometer is configured to measure a received wavefront. The aberrometer includes a wavefront sensor and a transfer optical system for transferring an input wavefront so as to the provide the received wavefront at or near the wavefront sensor. The system also includes a processor in communication with the aberrometer, a readable memory, and instructions located within the memory. The readable memory contains one or more system error parameters and instructions for calculating the input wavefront based on the received wavefront and the one or more system error parameters.

20020068066, Jun 6, 2002

Jun 15, 2001

09/881823

Wenyuan Shi - Los Angeles CA, US
Sherie Morrison - Los Angeles CA, US
Kham Trinh - Alhambra CA, US
Letitia Wims - Culver City CA, US
Li Chen - Los Angeles CA, US
Maxwell Anderson - Seattle WA, US

A61K039/09

424/185100, 424/244100

Dental caries in man may be prevented or treated by oral ingestion of human or humanized murine monoclonal IgG and IgM antibodies that bind to surface antigens of cariogenic organisms, such as . The genetically engineered monoclonal antibodies engage the effector apparatus of the human immune system when they bind to cariogenic organisms, resulting in their destruction. In a preferred embodiment, monoclonal antibodies to cariogenic organisms are produced by edible plants, including fruits and vegetables, transformed by DNA sequences that code on expression for the desired antibodies. The antibodies are applied by eating the plants.

20030143234, Jul 31, 2003

Feb 14, 2002

10/077624

Wenyuan Shi - Los Angeles CA, US
Sherie Morrison - Los Angeles CA, US
Kham Trinh - Alhambra CA, US
Letitia Wims - Culver City CA, US
Li Chen - Los Angeles CA, US
Maxwell Anderson - Seattle WA, US
Fengxia Qi - Harbor City CA, US

A61K039/40
C07K016/46

424/178100, 530/391100

The present invention is based on the discovery of a composition that provides targeted anti-microbial effect. Specifically the composition contains a targeting moiety which recognizes a target microbial organism and an anti-microbial peptide moiety which has anti-microbial activity. In addition, the present invention provides methods of treating a microbial infection, e.g., on mucosal surfaces by using the compositions provided by the present invention.

20030228379, Dec 11, 2003

May 28, 2002

10/156278

Wenyuan Shi - Los Angeles CA, US
Li Chen - Los Angeles CA, US
Maxwell Anderson - Seattle WA, US

A61K035/78

424/725000

The present invention provides compositions of herbs and methods of using the compositions for treating and preventing microbial infection, especially dental caries or periodontal disease.

20040052814, Mar 18, 2004

Jul 19, 2001

09/910358

Wenyuan Shi - Los Angeles CA, US
Sherie Morrison - Los Angeles CA, US
Kham Trinh - Alhambra CA, US
Letitia Wims - Culver City CA, US
Li Chen - Los Angeles CA, US
Maxwell Anderson - Seattle WA, US

A61K039/02
A61K039/002
C07K014/44
C07K014/195
C07K014/39
C07K014/375

424/190100, 424/191100, 530/350000

Microbial infection may be treated by administration of a fusion protein comprising one or more recognition sequences and at least one antimicrobial peptide. In preferred embodiments, a linker peptide connects the recognition sequence and one or more antimicrobial peptides. The recognition sequence may be an immunoglobulin molecule, or fragment thereof, that specifically binds to a target antigen present on a pathogen. The recognition sequence may also be a non-immunological polypeptide, providing that the polypeptide binds specifically to a particular ligand. In presently preferred embodiments the recognition sequence is monoclonal antibody that binds specifically to and the antimicrobial peptides are derivatives of histatin.